Faculty Profile for Dr. Liqin Du

profile photo for Dr. Liqin Du
Dr. Liqin Du
Associate Professor — Chemistry and Biochemistry
CHEM 212
phone: (512) 245-1038
Scholarly/Creative Work
Awards
Grants
Service

Biography Section

Biography and Education

 2009: Postdoctoral Fellow, McDermott Center for Human Growth and Development, UT Southwestern Medical Center at Dallas, Dallas, TX.

2004: Nutritional Sciences, University of Kentucky, Lexington, KY.

1998: Master of Medicine, Shanghai Second Medical University, Shanghai, China.

1992: Bachelor of Medicine (MD equivalent), Shanghai Medical University, Shanghai, China.

Teaching Interests

 1, Molecular Biology; 2, Cancer Biology; 3, Cell Biology; 4, Biochemistry.

Research Interests

 1, Cell differentiation in childhood tumorigenesis; 2, Differentiation therapy; 3, Natural products as anti-cancer agents; 4, Synthetic small-molecular compounds as anti-cancer agents; 5, non-coding RNAs in tumorigenesis and cancer therapy

Selected Scholarly/Creative Work

  • Zhao, G., Du, L., Zhang, L., & Jia, Y. (2021). LIM domain only 1: an oncogenic transcription cofactor contributing to the tumorigenesis of multiple cancer types. Chinese Medicine Journal, 134(9), 1017–1030. https://doi.org/10.1097/CM9.0000000000001487
  • Zhao, Z., Shelton, S. D., Oviedo, A., Baker, A. L., Bryant, C. P., Omidvarnia, S., & Du, L. (2020). The PLAGL2/MYCN/miR-506-3p interplay regulates neuroblastoma cell fate and associates with neuroblastoma progression. Journal of Experimental and Clinical Cancer Research, 39(1), 41. https://doi.org/10.1186/s13046-020-1531-2.
  • Vernaza, A., Cardus, D. F., Smith, J. L., Partridge, V., Baker, A. L., Lewis, E. G., … Du, L. (n.d.). Identification of CDKN3 as a Key Gene that Regulates Neuroblastoma Cell Differentiation. Journal of Cancer, 15(5), 1153–1168.
  • Mesa-Diaz, N., Smith, M. T., Cardus, D. F., & Du, L. (2023). Development of Shortened miR-506-3p Mimics Exhibiting Strong Differentiation-Inducing Activity in Neuroblastoma Cells. Molecules, 28(17), 1–15. Retrieved from https://doi.org/10.3390/molecules28176295
  • C., A. J., Oviedo, A., Zhao, Z., Du, L., & Kornienko, A. V. (2023). Discovery of 5-sulfonyltetrazoles as neuroblastoma differentiation agents. Bioorg. Med. Chem. Lett., 94, 1–4. Retrieved from https://doi.org/10.1016/j.bmcl.2023.129455

Selected Awards

  • Award / Honor Recipient: Hua Rui Prize, Sino-Swed Pharmaceutical Corp. Ltd. 1997
  • Award / Honor Recipient: Scholarship for Outstanding Graduate, Shanghai Second Medical University, China. 1996
  • Award / Honor Recipient: Scholarship for Outstanding Graduate, Shanghai Second Medical University, China. 1995
  • Award / Honor Recipient: First Prize of People’s Scholarship, Shanghai Medical University, China. 1991
  • Award / Honor Recipient: First Prize of People’s Scholarship, Shanghai Medical University, China. 1990

Selected Grants

  • Du, Liqin (Principal). Molecular and therapeutic mechanisms of differentiation-inducing microRNA miR-506-3p in neuroblastoma, National Institute of Health, NCI, R15, Federal, $445639. (Submitted: June 6, 2019, Funded: September 1, 2020 - August 31, 2023). Grant.
  • Du, Liqin (Principal), Kornienko, Alexander (Other), Houhgton, Peter (Other). Discovery of new differentiation agents for neuroblastoma therapy, National Institute of Health, NCI, R15, resubmissiom, Federal, $461574. (Funded: August 1, 2017 - July 31, 2020). Grant.
  • Du, Liqin (Principal). Developing novel miR-506-3p analogs that induce neuroblastoma cell differentiation, Texas State University, REP Program, Texas State University, $8000. (Submitted: October 8, 2019, Funded: January 15, 2020 - December 31, 2021). Grant.
  • Du, Liqin (Principal). Determining the therapeutic potential of rooperol in neuroblastoma, Texas State University, REP Program, Texas State University, $8000. (Funded: January 1, 2017 - May 31, 2018). Grant.
  • Kerwin, S (Principal), Du, Liqin (Co-Principal). Hypoxis-derived treatment for advanced lung cancer, William and Ella Owens Medical Research Foundation, Research grant, Private / Foundation / Corporate, $153109. (Funded: January 1, 2016 - December 31, 2017). Grant.

Selected Service Activities

Member
Department Space Committee
2021-Present
Member
Department Personnel Committee
2021-Present
Member
COSE Undergraduate Scholarship Committee
2021-Present
Editorial Review Board Member
Technology in Cancer Research and Treatment (TCRT)
October 2021-Present
Member
Biochemistry Graduate Curriculum committee
2016-Present